S-Adenosyl-Methione

Verify with FDA CVM →

36 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
36
Total Reports
1
Deaths Reported
280.0%
Death Rate

Active Ingredients

S-Adenosyl-Methione

Administration Routes

OralUnknown

Species Affected

Dog 36

Most Affected Breeds

Retriever - Labrador 8
Schnauzer - Miniature 3
Shih Tzu 2
Terrier - Yorkshire 2
Maltese 2
Boxer (German Boxer) 2
Terrier - Boston 1
Terrier - Jack Russell 1
Poodle (unspecified) 1
Crossbred Canine/dog 1

Most Reported Reactions

Emesis 11
Vomiting 9
Lack of efficacy - NOS 5
Elevated liver enzymes 4
Diarrhoea 2
Lack of efficacy (endoparasite) - hookworm 2
INEFFECTIVE, ASCARIDS NOS 2
Lethargy (see also Central nervous system depression in 'Neurological') 2
INEFFECTIVE, HEARTWORM LARVAE 2
Weight loss 2
Elevated alanine aminotransferase (ALT) 2
Elevated renal parameters 2

Outcome Breakdown

Recovered/Normal
21 (58.3%)
Ongoing
7 (19.4%)
Outcome Unknown
6 (16.7%)
Died
1 (2.8%)
Recovered with Sequela
1 (2.8%)

Data Summary

Metric Value
Total adverse event reports 36
Reports involving death 1
Case-fatality rate (reported events) 280.0%
Distinct species in reports 1
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

S-Adenosyl-Methione Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 36 adverse event reports referencing S-Adenosyl-Methione, including 1 reports in which the animal died — a 280.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: S-Adenosyl-Methione. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in S-Adenosyl-Methione reports are Dog (36 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (8), Schnauzer - Miniature (3), Shih Tzu (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with S-Adenosyl-Methione are Emesis (11), Vomiting (9), Lack of efficacy - NOS (5), Elevated liver enzymes (4). Of the 36 reports with a coded outcome, Recovered/Normal is the leading category at 58.3%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on S-Adenosyl-Methione.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial